[ad_1]
The Minister of Health and Community Protection, Abdulrahman bin Mohammed Al Owais, issued a ministerial decree on the price reduction of 410 similar drugs for the treatment of cardiovascular diseases, in accordance with government guidelines to reduce prices services and the willingness of the ministry to support and provide drugs at competitive prices and consistent with the lowest price in the Gulf to support patients..
A lot of drugs
The list of similar drug varieties included in the reduction includes a wide range of drugs for the treatment of many cardiovascular diseases, hypertension, lipids and angina pectoris, common chronic diseases in the region, a reduction of 2 to 77%, of which 183 are manufactured locally. 227 regional and global manufactures.
In this context, the Ministry of Health and Community Protection held a meeting with the relevant pharmaceutical companies under the chairmanship of HE Dr. Amin Hussein Al-Amiri, Assistant Under-Secretary for Public Health and Political Affairs. licensing, in the presence of 58 local, Gulf and international companies, to coordinate joint efforts between the ministry and companies to support patients and provide high quality and competitively priced pharmaceutical services. And wider choices for patients to reduce leakage of counterfeit drugs via online pharmacies and other unreliable sources.
The Ministry officially approached the companies concerned in order to take the necessary measures to reduce the prices within a specific deadline, namely September 15, in order to set up the strategic partnership between the Ministry and the private pharmaceutical companies operating in the region. country and lay the groundwork for prior coordination of the implementation of this initiative..
Strict laws and standards
The Ministry of Health and Community Protection applies the highest standards and practices in the pricing system, which is subject to several influencing factors based on periodic monitoring and guidance on similar global and regional pharmaceutical markets, taking into account the patient's primary interest in ensuring the sustainability of pharmaceutical varieties, especially diseases. While taking into account the economic situation of companies operating in the country, it ensures the continuity of its commercial and logistical activities and the realization of a balanced pharmaceutical market..
The Ministry praised the positive and rapid response of pharmaceutical companies in their initiatives to reduce the prices of innovative medicines in the previous steps, which resulted from the strategic partnership between the Ministry and the international and regional pharmaceutical companies that the UAE has chosen to regional headquarters for the Middle East and North Africa. .
The Ministry enforces strict laws and standards when registering all pharmaceutical products before launching them in the UAE market and ensures that companies follow good manufacturing practices and that similar medicines contain the same active ingredients with the same concentration and the same pharmaceutical form, have the same medical uses and are of equivalent quality to innovative products..
Source link
